Boots sold to Weston family’s Wittington Investments for US$8.9B

Boots has been sold to Wittington Investments for US$8.9 billion. The purchase includes assumed debt. Wittington will acquire Boots’ retail operations.

Boots sold to Weston family’s Wittington Investments for US$8.9B
Source image: Personal Care Insights

Boots has been sold to Wittington Investments for US$8.9 billion. The purchase includes assumed debt. Wittington will acquire Boots’ retail operations.

What happened

Boots has been sold to Wittington Investments for US$8.9 billion.

Why it matters

Wittington will acquire Boots’ retail operations in the UK and Ireland, Boots Opticians, No7 Beauty Company, and its Thailand and franchised businesses.

Before the breaking news deal, the UK pharmacy and beauty retailer was mostly owned by US private equity firm Sycamore Partners, in partnership with Stefano Pessina and his family.

The two parties will retain ownership of The Boots Group’s interests in Mexican pharmacy chain Farmacias Benavides and German pharmaceutical wholesaler, Alliance Healthcare Deutschland.The transaction is subject to regulatory approvals and the satisfaction of customary closing conditions and is expected to finalize in the first quarter of 2027.Store upgrade plansWittington is a holding company of the Weston family based in Canada.

This news brief is based on reporting published by Personal Care Insights on 2026-10-07. The original report is linked below.

Original source

Personal Care Insights

https://www.personalcareinsights.com/news/boots-sold-wittington-investments.html

This independent news brief is based on the public source identified above. It is an original summary or translation, not a reproduction of the source article. Rights in source text, research, trademarks and images remain with their respective owners; images are used under the licence or permission identified in the credit. Rights holders may contact rights@goodproductasia.com with evidence of ownership. Verified concerns will be corrected, replaced or removed promptly. This report is not investment, legal, medical or purchasing advice.